Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Next-generation sequencing (NGS) has revolutionized genome biology by enabling rapid whole-genome sequencing (WGS) and driving its adoption in research and clinical settings. However, the high-throughput nature of NGS and the complexity of downstream analyses demand robust computational solutions. We present GeNePi, a modular bioinformatic pipeline for efficient and accurate analysis of WGS short paired-end reads. GeNePi is a genomics analysis pipeline built on the Nextflow framework, integrating graphics processing unit (GPU)-accelerated algorithms from NVIDIA Clara Parabricks to enable high-performance variant discovery. The pipeline supports multiple workflow configurations and automates the detection of a broad range of genomic variants, including single-nucleotide variants and small insertions/deletions via GPU-accelerated HaplotypeCaller, copy number variants (CNVs) using CNVkit, and structural variants through a consensus approach combining Manta, Lumpy, BreakDancer, and CNVnator. Additionally, GeNePi incorporates MELT for the detection of mobile element insertions, providing a comprehensive framework for variant discovery and characterization. Benchmarking on synthetic and real datasets demonstrates high accuracy and performance comparable to state-of-the-art tools such as Genome Analysis ToolKit (GATK), establishing GeNePi as a scalable solution for comprehensive WGS analysis. These features make GeNePi a valuable instrument for large-scale analyses in both research and clinical contexts, representing a key step towards the establishment of National Centers for Computational and Technological Medicine.